Age
Item
1. the subject is 18 years old or older.
boolean
C0001779 (UMLS CUI [1])
Gender | Breast Feeding | Male sterilization | Female Sterilization | Bilateral oophorectomy | Hysterectomy | Postmenopausal state | Amenorrhea | Childbearing Potential Serum pregnancy test (B-HCG) Negative | Childbearing Potential qualitative urine human chorionic gonadotropin measurement Negative
Item
2. male subjects or non-lactating female subjects, who are either surgically sterile (has had a documented bilateral oophorectomy and/or documented hysterectomy), postmenopausal (cessation of menses for more than 1 year), or for women of childbearing potential, the results of a serum or urine human chorionic gonadotropin pregnancy test, performed at screening within 24 hours before dosing (with the result known before investigational medicinal product administration) must be negative.
boolean
C0079399 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0024559 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0278321 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C0232970 (UMLS CUI [7])
C0002453 (UMLS CUI [8])
C3831118 (UMLS CUI [9,1])
C0430060 (UMLS CUI [9,2])
C1513916 (UMLS CUI [9,3])
C3831118 (UMLS CUI [10,1])
C2188702 (UMLS CUI [10,2])
C1513916 (UMLS CUI [10,3])
Protocol Compliance | SPECT Stress Quantity | SPECT At rest Quantity | Informed Consent
Item
3. the subject is able and willing to comply with study procedures (i.e., 1 spect imaging at stress, 2 spect imagings at rest) and signed and dated informed consent is obtained.
boolean
C0525058 (UMLS CUI [1])
C0040399 (UMLS CUI [2,1])
C0038435 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0040399 (UMLS CUI [3,1])
C0443144 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0021430 (UMLS CUI [4])
Coronary Artery Disease Sign or Symptom | Coronary Artery Disease Symptoms | Coronary Artery Disease Examination
Item
4. the subject is suspected of or known of having cad based on the subject's clinical signs, symptoms, or examinations .
boolean
C1956346 (UMLS CUI [1,1])
C3540840 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
C1956346 (UMLS CUI [3,1])
C0031809 (UMLS CUI [3,2])
Combined stress and rest myocardial perfusion study Coronary Artery Disease | SPECT Coronary Artery Disease | Combined stress and rest myocardial perfusion study Exercise | SPECT pharmacological | Combined stress and rest myocardial perfusion study pharmacological | SPECT Exercise
Item
5. the subject is referred for rest/stress (exercise or pharmacological) mps-spect for known or suspected cad (as clinically required).
boolean
C0846078 (UMLS CUI [1,1])
C1956346 (UMLS CUI [1,2])
C0040399 (UMLS CUI [2,1])
C1956346 (UMLS CUI [2,2])
C0846078 (UMLS CUI [3,1])
C0015259 (UMLS CUI [3,2])
C0040399 (UMLS CUI [4,1])
C0205464 (UMLS CUI [4,2])
C0846078 (UMLS CUI [5,1])
C0205464 (UMLS CUI [5,2])
C0040399 (UMLS CUI [6,1])
C0015259 (UMLS CUI [6,2])
Study Subject Participation Status
Item
1. the subject was previously included in this study.
boolean
C2348568 (UMLS CUI [1])
Investigational New Drugs
Item
2. the subject received an imp within 30 days before or is scheduled to receive one during or in the next 30 days after imp administration.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drugs Constituents | Exercise Unable | Medical contraindication Adenosine | Asthmatics
Item
3. the subject has known allergies to any product used in this study or its constituents, including subjects who are not able to exercise and have contraindications to adenosine (e.g., asthmatics).
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0729650 (UMLS CUI [2,3])
C0015259 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0001443 (UMLS CUI [4,2])
C3816164 (UMLS CUI [5])
Disease Serious | Life threatening illness | Life Expectancy
Item
4. the subject presents any clinically active, serious, life-threatening disease, with a life expectancy of less than 1 month.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3846017 (UMLS CUI [2])
C0023671 (UMLS CUI [3])
Medical contraindication Study Procedures | Medical contraindication Exercise | Medical contraindication Myoview | Medical contraindication Thallium-201 | Medical contraindication Adenosine | Medical contraindication Dipyridamole | Second degree atrioventricular block | Complete atrioventricular block | Sick Sinus Syndrome | Bradycardia | Bronchoconstriction | Bronchial Spasm
Item
5. the subject has no contraindications to any of the study procedures (e.g. physical exercise) or the involved drugs (myoview, thallium-201, adenosine or dipyridamole) such as e.g. 2nd or 3rd degree av-block, ss syndrome, bradycardia, bronchoconstrictive or bronchospastic lung disease.
boolean
C1301624 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
C1948041 (UMLS CUI [1,3])
C1301624 (UMLS CUI [2,1])
C0015259 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0379804 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0303322 (UMLS CUI [4,2])
C1301624 (UMLS CUI [5,1])
C0001443 (UMLS CUI [5,2])
C1301624 (UMLS CUI [6,1])
C0012582 (UMLS CUI [6,2])
C0264906 (UMLS CUI [7])
C0151517 (UMLS CUI [8])
C0037052 (UMLS CUI [9])
C0428977 (UMLS CUI [10])
C0079043 (UMLS CUI [11])
C0006266 (UMLS CUI [12])